Connect with us

Health

Council reaches deal on Critical Medicines Act, but level of ambition questioned

SHARE:

Published

7 months ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

EU ministers backed a joint negotiating position on the Critical Medicines Act agreement, but some consider it a missed opportunity.
This afternoon (2 December), the Council agreed its “general approach” to the Critical Medicines Act (CMA), which aims to tackle shortages and improve the security of supply by re-shoring or friend-shoring the production of critical medicines within the EU.
Danish Health Minister and Minister for the Interior, Sophie Løhde, described the agreement as “an important step” towards ensuring that European patients have access to the medicines they need: “The Critical Medicines Act will...

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending